Hydrochloric Acid → 1-[(1-Benzylpiperidin-3-yl)methyl]piperazin-2-one dihydrochloride
反応式
[CH2:1]([N:8]1[CH2:13][CH2:12][CH2:11][CH:10]([CH2:14][N:15]2[CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17][C:16]2=[O:28])[CH2:9]1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[ClH:29]>ClCCl.O1CCOCC1>[ClH:29].[ClH:29].[CH2:1]([N:8]1[CH2:13][CH2:12][CH2:11][CH:10]([CH2:14][N:15]2[CH2:20][CH2:19][NH:18][CH2:17][C:16]2=[O:28])[CH2:9]1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1参加物
5
実験手順
To a solution of tert-butyl 4-[(1-benzylpiperidin-3-yl)methyl]-3-oxopiperazine-1-carboxylate (95 mg) in dichloromethane (1 mL) was added 4M hydrochloric acid in dioxane (1 mL). The mixture was stirred at room temperature for 15 minutes and then evaporated to give the title compound as a sticky white solid (89 mg, 100%).
後処理
- customevaporated
出典と根拠
- ORDレコード
- ord-0e2b7747ec7a4b0f88a1e5c05f460ca3
- 出典データセット
- uspto-grants-2011_03
- 特許番号
- US07906645B2
反応ノート
読み込み中…